The model was adjusted by age, sex, smoking, drinking, obesity, past history of impaired glycometabolism or diabetes, including current use of insulin or glucose-lowering agents, past history of dyslipidemia, including current use of lipid lowering agents, or past history of hepatic impairment. This evidence concerns the gene INS and metabolic syndrome.